METHODS OF ADMINISTERING THERAPY

The present invention relates to improved methods of administering compound 1 therapy, involving increased effectiveness of compound 1 by avoiding or contraindicating combined CYP3A4/P-gp inducers, e.g. rifampicin. La présente invention concerne des procédés améliorés d'administration d'un...

Full description

Saved in:
Bibliographic Details
Main Authors DESRIVOT, Julie, NAMOUR, Florence
Format Patent
LanguageEnglish
French
Published 13.02.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to improved methods of administering compound 1 therapy, involving increased effectiveness of compound 1 by avoiding or contraindicating combined CYP3A4/P-gp inducers, e.g. rifampicin. La présente invention concerne des procédés améliorés d'administration d'une thérapie du composé 1, impliquant une efficacité accrue du composé 1 en évitant ou en contre-indiquant des inducteurs de CYP3A4/P-gp combinés, par exemple la rifampicine.
Bibliography:Application Number: WO2019EP71170